Q3 2025 Holdings
Filed 2025-11-14 | 35 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $157.8M | 6,100,729 | 11.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $131.1M | 8,520,000 | 9.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $117.0M | 4,027,800 | 8.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $113.2M | 7,886,172 | 8.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $110.6M | 3,071,588 | 8.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $95.6M | 4,427,927 | 7.1% |
| CG Oncology Inc(CGON) | COM | 156944100 | $80.8M | 2,005,205 | 6.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $71.3M | 9,390,270 | 5.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $61.1M | 2,517,647 | 4.5% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $36.7M | 1,009,267 | 2.7% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $35.0M | 2,000,000 | 2.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $34.1M | 4,994,090 | 2.5% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $33.4M | 4,560,053 | 2.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $32.6M | 2,329,998 | 2.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $22.7M | 949,727 | 1.7% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $21.3M | 2,145,319 | 1.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $20.0M | 2,168,605 | 1.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $20.0M | 67,588 | 1.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $18.3M | 808,607 | 1.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $16.8M | 675,000 | 1.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $15.1M | 2,887,014 | 1.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $13.7M | 2,302,172 | 1.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $11.6M | 3,646,503 | 0.9% |
| Amarin Corp PLC(EH3) | SPONSORED ADR | 023111404 | $9.4M | 576,111 | 0.7% |
| Burning Rock Biotech LTD(BNR) | SPONSORED ADS | 12233L206 | $8.6M | 994,883 | 0.6% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $7.8M | 1,029,579 | 0.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $7.4M | 606,171 | 0.5% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $7.2M | 5,466,825 | 0.5% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $7.1M | 3,067,774 | 0.5% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $6.9M | 282,412 | 0.5% |
| Geron Corp(GERN) | COM | 374163103 | $4.7M | 3,456,318 | 0.4% |
| Sutro Biopharma Inc | COM | 869367102 | $4.4M | 5,088,099 | 0.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.1M | 253,979 | 0.3% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $3.5M | 1,649,462 | 0.3% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $2.1M | 1,028,341 | 0.2% |